| Ruth L. Kirschstein National Research Service Award Program |
Training Initiative |
AHRQ, HRSA |
OD/OER |
The National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Award program provides predoctoral and postdoctoral training to meet the nation’s need for investigators in biomedical, behavioral, and clinical research. In accordance with the Public Health Service Act and annual appropriations acts, NIH annually transfers a portion of these funds to the Agency for Healthcare Research and Quality and Health Resources and Services Administration to foster the training of health services and primary care researchers. |
| RxNorm |
Resource Development |
FDA |
NLM |
RxNorm provides normalized names for generic and branded drugs and links its names to many of the drug vocabularies commonly used in pharmacy management and drug interaction software. By providing links between these vocabularies, RxNorm can facilitate communication between systems that use different software and vocabulary. http://www.nlm.nih.gov/research/umls/rxnorm/ |
| SARS CoV-2 Risk Group and Biosafety Level Working Group |
Committee, Work group, Advisory group, or Task Force |
CDC |
OD/OM, OD/OM/ORS |
Discussed and made recommendation on risk level and biosafety level for SARS-CoV-2 |
| SARS-CoV-2 Assay Development, Training, and Standardization |
Committee, Work group, Advisory group, or Task Force |
FDA |
NIAID |
SARS-CoV-2 Assay Development, Training, and Standardization in BSL4 lab at Integrated Research Facility, Fort Dietrick |
| SARS-CoV-2 Assessment of Viral Evolution Program |
Committee, Work group, Advisory group, or Task Force |
ASPR, CDC, FDA |
NIAID |
SAVE provides a comprehensive real-time risk assessment of emerging mutations in SARS-CoV-2 that could impact transmissibility, virulence, and susceptibility to infection- or vaccine-induced immunity. The goals of the SAVE program are to understand emerging changes in the virus that could impact transmissibility, virulence, susceptibility to convalescent and vaccine-induced immunity and diagnostic testing. |
| SARS-CoV-2 Interagency Group on Diagnostics |
Committee, Work group, Advisory group, or Task Force |
CDC, FDA |
NIAID |
SARS-CoV-2 interagency Working Group aimed at evaluating the impact of SARS-CoV-2 variants on COVID-19 diagnostics |
| SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology, and Surveillance |
Committee, Work group, Advisory group, or Task Force |
CDC |
NIAID |
A new national genomics consortium to coordinate SARS-CoV-2 sequencing across the United States |
| Scientific Registry of Transplant Recipients (SRTR) Visiting Committee |
Committee, Work group, Advisory group, or Task Force |
HRSA |
|
The SRTR Visiting Committee advises the SRTR on:(1) analytic methodologies to support the Organ Procurement and Transplantation Network policy development and evaluation; (2) objectives, study designs, and statistical methods for research projects performed by SRTR, including risk-adjusted analyses of organ procurement organization and transplant program performance; (3) methods used in simulated allocation models; (4) new areas of research and innovative advances in analytical methodologies that might improve the effectiveness of SRTR. |
| Secretary’s Initiative on Protecting Farmworkers from Extreme Heat and Wildfire Smoke |
Other |
CDC, HRSA, SAMHSA |
NIEHS, NIMHD, NINR |
Proposed by the HHS Secretary. It intends to facilitate communication and collaboration across HHS agencies on research, policy, and healthcare services to protect farmworkers from extreme heat and wildfire smoke (the latter related to more recent climate events in various states. |
| Secretary's Advisory Committee on Human Research Protections |
Committee, Work group, Advisory group, or Task Force |
OASH, AHRQ, CDC, FDA, HRSA, IHS, OCR, ONC |
OD/OSP |
The Secretary’s Advisory Committee on Human Research Protections (SACHRP) provides expert advice and recommendations to the Secretary of HHS on issues pertaining to the protection of human subjects in research. |